Key result
Inhibiting elevated miR-9-3p reduces cardiomyocyte inflammation in AMI by targeting IGF2.
Why the study?
The incidence of AMI is continuously increasing globally, and the effect of the miR-9-3p/IGF2 signaling axis on the inflammatory response in a hypoxia/reoxygenation model warranted investigation.
Does the miR-9-3p/IGF2 signaling axis regulate cell viability and the inflammatory response in hypoxic-reoxygenated cardiomyocytes and patients with acute myocardial infarction?
Case-Control (n=180)
Does the miR-9-3p/IGF2 signaling axis regulate cell viability and the inflammatory response in hypoxic-reoxygenated cardiomyocytes and patients with acute myocardial infarction?
This study identifies that the miR-9-3p/IGF2 signaling axis modulates cardiomyocyte viability and inflammation during hypoxia/reoxygenation, suggesting a potential molecular target for acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
miR-9-3p/IGF2 axis merits mechanistic study in AMI inflammation; leaves open diagnostic or therapeutic utility pending validation.
Globally, the incidence of acute myocardial infarction (AMI) is continuously increasing, which seriously affects the safety of patients with high blood sugar and high blood lipids. This study aimed to explore the effect of the miR-9-3p/insulin-like growth factor2 (IGF2) signaling axis on the hypoxia/reoxygenation (H/R) model. 78 non-AMI subjects and 102 patients with AMI were recruited in this study. miR-9-3p expression and IGF2 expression were detected by RT-qPCR. The pro-inflammatory factors and anti-inflammatory factors were detected by ELISA. A dual luciferase assay was used to verify the targeting relationship between miR-9-3p and IGF2. Multivariate logistic regression was used to explore the independent influencing factors of AMI. miR-9-3p level was increased in AMI patients and in the H/R model. However, IGF2 expression was decreased. After transfection with the miR-9-3p inhibitor, cell viability was significantly increased, the secretion levels of pro-inflammatory factors were significantly decreased, and the levels of anti-inflammatory factors were increased in the H/R model. The dual-luciferase reporter gene assay indicated that IGF2 was the target gene of miR-9-3p. H9c2 cells were transfected with the si-IGF2, and the results showed that cell viability decreased, the secretion levels of pro-inflammatory factors were increased, and the levels of anti-inflammatory factors were reduced. IGF2 partially reversed the effect of miR-9-3p. The expression of miR-9-3p was elevated in AMI patients and the H/R model. However, the IGF2 level was decreased. The miR-9-3p/IGF2 signaling axis may regulate the inflammatory response in AMI. Not applicable.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a case-control in Acute myocardial infarction (AMI) (n=180). miR-9-3p/IGF2 signaling axis expression vs. Non-AMI control subjects (and control H9c2 cells in in vitro hypoxia/reoxygenation experiments) was evaluated on Expression levels of miR-9-3p and IGF2, cardiomyocyte viability, and inflammatory cytokine secretion. miR-9-3p was elevated and IGF2 decreased in 102 AMI patients vs 78 non-AMI controls; inhibiting miR-9-3p targeted IGF2 to reduce cardiomyocyte inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: